News Novo completes major filings for blockbuster hope semaglutid... Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan.
News Patient death raises concerns over Roche haemophilia drug Concerns following event on HAVEN1 trial.
News Pfizer, Novo invest in Swedish patient stratification startu... Funds will go towards development of AMRA's body composition profiling tool AMRA Profiler.
Views & Analysis Digital health round-up – health innovations shine at CES 20... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
